Uvilla para Actividad antiinflamatoria
Cissus verticillata — 6 estudios científicos revisados
Preliminary¿Sirve Uvilla para actividad antiinflamatoria?
La investigación científica ha explorado el potencial de Uvilla (Cissus verticillata) en relación con actividad antiinflamatoria. Se han identificado 6 estudios relevantes que examinan esta relación.
Compuestos activos involucrados: Flavonoides, Saponinas, Terpenos, Distribuido, Compuestos fenólicos
Evidencia Científica
Los siguientes estudios han investigado la relación entre Uvilla y actividad antiinflamatoria:
Cissus verticillata (L.) Nicolson and C.E. Jarvis (Vitaceae): Its identification and usage in the sources from 16th to 19th century.
ETHNOPHARMACOLOGICAL RELEVANCE: Cissus verticillata (L.) Nicolson and C.E. Jarvis is best known for its hypoglycaemic and anti-lipemic action. In Brazilian ethnopharmacy it is called "plant-insulin" and used mostly against diabetes, as well as in abscesses, haemorrhage and epilepsy. In the present paper we study the past significance of this plant recorded between 1571 and 1829 both in ethnic (Mexico, Haiti) and official (European) pharmacies. AIM OF THE STUDY: (1) We are able to identify Carolus Sanctus and Lupulus Mechiocanus from Renaissance and later sources as Cissus verticillata.
PubMed: 26074377Cissus Extracts in Dentistry: A Comprehensive Review on its Untapped Potential.
Natural products have received a lot of attention in a variety of medical sectors, including dentistry. Cissus, a flowering plant genus, has long been used for its therapeutic benefits. The purpose of this review is to thoroughly investigate the possibilities of Cissus extracts in dentistry. To that end, we used specific selection criteria for the selection of pertinent scientific articles published in the scientific information databases of PubMed, Web of Science, Google Scholar, Scopus, and ProQuest. We found that the diverse array of bioactive compounds found in varied species of Cissus hol
PubMed: 38595361Cissus verticillata Leaf Extract Decreases the Production of AGEs and ROS In Vitro.
Cissus verticillata (plant-insulin) is used in the Brazilian popular medicine to treat symptoms of diabetes. Studies about its ability to contrast glycoxidative stress is lacking, which may add mechanistic information about its effects on treat diabetic complications. This study investigated the ability of Cissus verticillata leaf hydroethanolic extract (CvExt) to scavenge reactive oxygen species (ROS) and to inhibit the formation of advanced glycation end products (AGEs). ROS scavenging assays were used to test CvExt antioxidant activity. Incubations of bovine serum albumin with glucose (0.5
PubMed: 41752474Unlocking the medicinal arsenal of
BACKGROUND AND AIMS: This study investigated the biochemical components present in the leaves of METHODOLOGY: Fourier Transform Infrared (FT-IR) spectroscopy, Gas Chromatography-Mass Spectrometry (GC-MS), and Mass Spectral analysis were employed to identify and characterize the compounds in RESULTS AND DISCUSSION: FT-IR spectroscopic analysis revealed significant molecular vibrations at frequencies of 3265.63, 2853.81, 1638.60, 1469.21, and 1384.95 cm⁻¹, indicating the presence of specific functional groups. The GC-MS analysis identified distinct compounds, such as "aR-Turmerone," "Curlone,"
PubMed: 39328981Acute and subacute toxicity of the aqueous extract of Cissus Polyantha Glig and Bradt (Vitaceae) on biochemical and hematological parameters in Wistar rats.
BACKGROUND: Cissus polyantha (C. polyantha) Glig and Bradt is a climbing plant of the Vitaceae family generally distributed in tropical regions and used in traditional African pharmacopoeia for the treatment of conjunctivitis, pain, inflammation, microbial diseases and diabetes mellitus. The aim of this study was to evaluate the acute and subacute toxicity of the aqueous extract from leafy stems of C. polyantha (AECP) in rats. METHODS: In acute toxicity, AECP was administered orally at a single dose of 2000 mg/kg.
PubMed: 40722010Seguridad y Precauciones
La seguridad en el uso de Cissus verticillata (Uvilla) es un área donde la evidencia científica clínica es extremadamente limitada, predominando el conocimiento etnobotánico sobre los estudios farmacológicos controlados en humanos. En cuanto al embarazo y la lactancia, existe una contraindicación absoluta para la administración de preparaciones internas (decocciones, infusiones o jugos) debido a la falta de estudios que garanticen la ausencia de efectos teratogénicos o alteraciones en el desarrollo fetal. Aunque en algunas tradiciones se menciona el uso externo de cataplasmas de hojas para facilitar el parto, este es un uso empírico que no debe sustituir la asistencia médica profesional. No se dispone de datos suficientes sobre la excreción de metabolitos de la planta a través de la leche materna, por lo que se recomienda evitar su consumo durante la lactancia para prevenir riesgos potenciales en el lactante. Respecto a la población pediátrica, los niños menores de 12 años no deben consumir ninguna parte de la planta por vía oral; la toxicidad en sistemas metabólicos inmaduros no ha sido evaluada y la planta posee propiedades laxantes que podrían causar desequilibrios electrolíticos severos en infantes. En términos de interacciones farmacológicas, la Uvilla requiere precaución extrema si se combina con fármacos que afecten la coagulación, como la warfarina, debido a la posibilidad de efectos sinérgicos que incrementen el riesgo de hemorragias, dado que muchas especies de la familia Vitaceae contienen compuestos con actividad biológica no plenamente caracterizada.
Otras plantas estudiadas para Actividad antiinflamatoria
Perfil completo: Ver todos los usos y evidencia de Uvilla →